76 related articles for article (PubMed ID: 36552995)
1. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
Bocchini M; Nicolini F; Severi S; Bongiovanni A; Ibrahim T; Simonetti G; Grassi I; Mazza M
Front Oncol; 2020; 10():831. PubMed ID: 32537434
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists.
Pellegrino F; Granata V; Fusco R; Grassi F; Tafuto S; Perrucci L; Tralli G; Scaglione M
Tomography; 2023 Jan; 9(1):217-246. PubMed ID: 36828370
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced harmonic endoscopic ultrasonography for pancreatobiliary diseases.
Kitano M; Kamata K; Imai H; Miyata T; Yasukawa S; Yanagisawa A; Kudo M
Dig Endosc; 2015 Apr; 27 Suppl 1():60-7. PubMed ID: 25639788
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced harmonic endoscopic ultrasonography in gallbladder cancer and pancreatic cancer.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Sato Y; Hikichi T; Ohira H
Fukushima J Med Sci; 2017 Aug; 63(2):39-45. PubMed ID: 28680009
[TBL] [Abstract][Full Text] [Related]
5. Contrast-Enhanced Harmonic Endoscopic Ultrasound for Diagnosis of the Aggressiveness of Pancreatic Neuroendocrine Neoplasm.
Tamura T; Sugihara Y; Yamazaki H; Koutani H; Tamura T; Tsuda I; Emori T; Kawaji Y; Hatamaru K; Yamashita Y; Itonaga M; Ashida R; Kitano M
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552995
[TBL] [Abstract][Full Text] [Related]
6. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms.
Ishikawa R; Kamata K; Hara A; Tanaka H; Okamoto A; Yamazaki T; Nakai A; Omoto S; Minaga K; Yamao K; Takenaka M; Minami Y; Watanabe T; Chiba Y; Chikugo T; Matsumoto I; Takeyama Y; Matsukubo Y; Hyodo T; Kudo M
Dig Endosc; 2021 Jul; 33(5):829-839. PubMed ID: 33020955
[TBL] [Abstract][Full Text] [Related]
7. Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuvant chemotherapy in patients with pancreatic cancer.
Yamashita Y; Ashida R; Kojima F; Okada KI; Kawai M; Yamazaki H; Tamura T; Kawaji Y; Tamura T; Hatamaru K; Itonaga M; Kitano M
Pancreatology; 2023 Dec; 23(8):1014-1019. PubMed ID: 37926599
[TBL] [Abstract][Full Text] [Related]
8. Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos).
Palazzo M; Napoléon B; Gincul R; Pioche M; Pujol B; Lefort C; Fumex F; Hautefeuille V; Fabre M; Cros J; Felce M; Couvelard A; Sauvanet A; Lévy P; Ruszniewski P; Palazzo L
Gastrointest Endosc; 2018 Jun; 87(6):1481-1488. PubMed ID: 29325706
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound.
Kataoka K; Ishikawa T; Ohno E; Mizutani Y; Iida T; Ishikawa E; Furukawa K; Nakamura M; Honda T; Ishigami M; Kawashima H; Hirooka Y; Fujishiro M
Pancreatology; 2021 Oct; 21(7):1364-1370. PubMed ID: 34281790
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced harmonic endoscopic ultrasonography for predicting the efficacy of first-line gemcitabine and nab-paclitaxel chemotherapy in pancreatic cancer.
Emori T; Ashida R; Tamura T; Kawaji Y; Hatamaru K; Itonaga M; Yamashita Y; Shimokawa T; Higashino N; Ikoma A; Sonomura T; Kawai M; Kitano M
Pancreatology; 2022 May; 22(4):525-533. PubMed ID: 35437177
[TBL] [Abstract][Full Text] [Related]
11. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
[TBL] [Abstract][Full Text] [Related]
12. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
[TBL] [Abstract][Full Text] [Related]
13. Role of Endoscopic Ultrasound in the Diagnosis of Pancreatic Neuroendocrine Neoplasms.
Ishii T; Katanuma A; Toyonaga H; Chikugo K; Nasuno H; Kin T; Hayashi T; Takahashi K
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33672085
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
